Use of octreotide as second-line treatment for concurrent chemoradiation induced diarrhea refractory to loperamide.

Basit Öğe Kaydı
dc.authoridTopkan, Erkan/0000-0001-8120-7123
dc.authoridselek, ugur/0000-0001-8087-3140
dc.authorwosidTopkan, Erkan/AAG-2213-2021
dc.authorwosidselek, ugur/O-5474-2014
dc.contributor.authorTopkan, E
dc.contributor.authorSelek, U
dc.date.accessioned2024-08-04T21:02:21Z
dc.date.available2024-08-04T21:02:21Z
dc.date.issued2004
dc.departmentİnönü Üniversitesien_US
dc.description40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LAen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.endpage295Sen_US
dc.identifier.issn0732-183X
dc.identifier.issue14en_US
dc.identifier.startpage295Sen_US
dc.identifier.urihttps://hdl.handle.net/11616/104693
dc.identifier.volume22en_US
dc.identifier.wosWOS:000223512401168en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleUse of octreotide as second-line treatment for concurrent chemoradiation induced diarrhea refractory to loperamide.en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu